Simple model of a photoacoustic system as a CR circuitFUKUHARA, Akiko; KANEKO, Fumitoshi; OGAWA, Naohisa et al.European journal of physics. 2012, Vol 33, Num 3, pp 623-635, issn 0143-0807, 13 p.Article

Antioxidant capacity of BO-653, 2,3-dihydro-5-hydroxy-4, 6-di-tert-butyl-2,2-dipentylbenzofuran, and uric acid as evaluated by ORAC method and inhibition of lipid peroxidationNIKI, Etsuo; FUKUHARA, Akiko; OMATA, Yo et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 7, pp 2464-2466, issn 0960-894X, 3 p.Article

Assessment of Radical Scavenging Capacity and Lipid Peroxidation Inhibiting Capacity of AntioxidantNIKI, Etsuo; OMATA, Yo; FUKUHARA, Akiko et al.Journal of agricultural and food chemistry (Print). 2008, Vol 56, Num 18, pp 8255-8260, issn 0021-8561, 6 p.Article

Characterization of cellular uptake and distribution of coenzyme Q₁₀ and vitamin E in PC12 cellsSAITO, Yoshiro; FUKUHARA, Akiko; NISHIO, Keiko et al.Journal of nutritional biochemistry. 2009, Vol 20, Num 5, pp 350-357, issn 0955-2863, 8 p.Article

Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancerMASAGO, Katsuhiro; FUJITA, Shiro; MISHIMA, Michiaki et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 2, pp 325-330, issn 0344-5704, 6 p.Article

Differences in adverse events between 250 mg daily gefitinib and 150 mg daily erlotinib in Japanese patients with non-small cell lung cancerTOGASHI, Yosuke; MASAGO, Katsuhiro; FUJITA, Shiro et al.Lung cancer. 2011, Vol 74, Num 1, pp 98-102, issn 0169-5002, 5 p.Article

Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancerMASAGO, Katsuhiro; FUJITA, Shiro; YUNG HAKU KIM et al.Cancer science. 2009, Vol 100, Num 10, pp 1917-1922, issn 1347-9032, 6 p.Article

Characterization of novel furan compounds on the basis of their radical scavenging activity and cytoprotective effects against glutamate-and lipopolysaccharide-induced insultsNISHIO, Keiko; FUKUHARA, Akiko; OMATA, Yo et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 24, pp 10332-10337, issn 0968-0896, 6 p.Article

Association of Diffuse, Random Pulmonary Metastases, Including Miliary Metastases, With Epidermal Growth Factor Receptor Mutations in Lung AdenocarcinomaTOGASHI, Yosuke; MASAGO, Katsuhiro; KUBO, Takeshi et al.Cancer. 2011, Vol 117, Num 4, pp 819-825, issn 0008-543X, 7 p.Article

Clinical Significance of Pretreatment C-Reactive Protein in Patients with Advanced Nonsquamous, Non-Small Cell Lung Cancer Who Received GefitinibMASAGO, Katsuhiro; FUJITA, Shiro; MIO, Tadashi et al.Oncology. 2010, Vol 79, Num 5-6, pp 355-362, issn 0030-2414, 8 p.Article

Association of the transforming growth factor ss1 promoter polymorphism, C-509T, with smoking status and survival in advanced non-small cell lung cancerTOGASHI, Yosuke; MASAGO, Katsuhiro; FUJITA, Shiro et al.Oncology reports. 2011, Vol 25, Num 2, pp 377-382, issn 1021-335X, 6 p.Article

Clinical significance of epidermal growth factor receptor mutations and insulin-like growth factor 1 and its binding protein 3 in advanced non-squamous non-small cell lung cancerMASAGO, Katsuhiro; FUJITA, Shiro; MISHIMA, Michiaki et al.Oncology reports. 2011, Vol 26, Num 4, pp 795-803, issn 1021-335X, 9 p.Article

Antioxidant action of sugar-pendant C₆₀ fullerenesHORIE, Masanori; FUKUHARA, Akiko; SAITO, Yoshiro et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 20, pp 5902-5904, issn 0960-894X, 3 p.Article

Clinical significance of pretreatment serum amphiregulin and transforming growth factor-α, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancerMASAGO, Katsuhiro; FUJITA, Shiro; HATACHI, Yukimasa et al.Cancer science. 2008, Vol 99, Num 11, pp 2295-2301, issn 1347-9032, 7 p.Article